Seborrheic dermatitis in COVID‐19: a case report

Abstract

This report analyzes the case of a 63-year-old Caucasian male, Fitzpatrick III phototype, who was admitted to the Intensive Care Unit (ICU) due to a severe coronavirus disease 2019 (COVID-19) pneumonia. The patient's medical history was remarkable for valvular heart disease, the presence of a biological aortic valve, and primary arterial hypertension, but he had no prior history of any dermatological complaints. The patient

Examination of Cutaneous Changes Among Patients Following SARS-CoV-2 Infection

“…A case similar to this, with new-onset seborrheic dermatitis during COVID-19 has been recorded in a case study previously [22]. There were some differences in this case, notably, the condition of the subject was more critical than the subject reported in this case [22]. Nevertheless, the similarities are consistent in the sense of developing a new skin condition after the onset of COVID-19 [22].…”

“…The patient referenced in Case 3 had never experienced lesions like this in the past, and their appearance occurred after the development of COVID-19 symptoms. A case similar to this, with new-onset seborrheic dermatitis during COVID-19 has been recorded in a case study previously [22]. There were some differences in this case, notably, the condition of the subject was more critical than the subject reported in this case [22].…”

“…There were some differences in this case, notably, the condition of the subject was more critical than the subject reported in this case [ 22 ]. Nevertheless, the similarities are consistent in the sense of developing a new skin condition after the onset of COVID-19 [ 22 ]. The clinician must be aware of the concomitant development of skin conditions, such as seborrheic dermatitis with COVID-19, so that they can be treated appropriately and further monitored for further development of the condition after recovery.…”

Lack of association between seborrheic dermatitis and SARS‐CoV‐2 outcomes

“…

patients with skin cancer, while reducing access to care for all. 3 The decrease in DEU activity suggests a change in the ways of general population, perhaps due to fear of long waiting times or crowd. Determining if this loss was either due to patients fears in healthcare facilities or to other factors needs to be investigated.

…”

“…1 A recent report of a severely ill SARS-CoV-2 patient developing SD suggests possible associations between these two conditions. 3 However, few studies examined potential associations between SD and SARS-CoV-2 outcomes. We investigated the relationship between SD and SARS-CoV-2 outcomes among adults with dermatologic disease.…”